Antimicrobial gallium compounds and methods
This invention relates to antimicrobial gallium compounds, and to monomers containing gallium complex moieties that can be used in oral care products and dental materials, and which can reduce or eliminate dental caries and bacterial or fungal infections associated with medical and dental devices.
1. A gallium-releasing composition, comprising a filler according to Formula (1) and a monomer according to Formula (2):
or a cured polymer thereof;
wherein, M is a positive ion of hydrogen, sodium, potassium, ammonium, or a quaternary ammonium;
wherein L is a chelating ligand; wherein X is an anion including hydroxide, nitrate, chloride, and fluoride;
wherein j is an integer from 0 to 4;
wherein 1 is an integer number from 1 to 3;
wherein m is an integer number from 0 to 6;
wherein n is an integer number from 0 to 6;
wherein k is an integer number from 1 to 3;
wherein, R is a substituted or unsubstituted aliphatic or aromatic group having 2 to 50 carbon atoms; and having at least one polymerizable group;
wherein, R′ is a substituted or unsubstituted aliphatic or aromatic group having 2 to 50 carbon atoms, and having at least one polymerizable group;
wherein, A is a substituted or unsubstituted aliphatic or aromatic linkage group having 1 to 100 carbon atoms,
wherein Formula (1) is loaded on a nanoparticle or nanotube;
wherein the composition comprises 0.1% to 20% of the filler according to Formula (1); and
wherein the composition comprises 0.1% to 20% of the monomer of Formula (2).
2. The composition of claim 1 , wherein L of Formula (1) is a chelating ligand comprising: oxalic acid, citric acid, phthalic acid, glutamic acid, tyrosine, serine, iminodiacetic acid, ethylenediiminodiacetic acid, nitrilotriacetic acid, catechol, acetylacetone, hexafluoroacetylacetone, benzoylacetone, N-(2- hydroxybenzyl)iminodiacetic acid, N-(2-hydroxyethyl)iminodiacetic acid, N-(2-aminoethyl)iminodiacetic acid, ethylendinitrilotetraacetic acid, diglycylethylenediaminetetraacetic acid, diethylenetrinitrilopentaacetic acid, salicylic acid, ethylenediiminodiacetic acid (EDDA), N,N-bis(carboxymethyl)aminoacetohydroxamic acid, ethylenediiminobis[(2-hydroxyphenyl)acetic acid] (EHPG), or diethylenetrinitrilopentaacetic acid (DTPA).
3. The composition of claim 1 , wherein L of Formula (2) is one of the following chelating groups L2-L22 with dotted line indicating bonding location:
4. The composition of claim 1 , wherein R and R′ are one of R1-R6:
wherein Y is selected from the group consisting of hydrogen, and an unsubstituted aliphatic group containing 1 to 6 carbons;
wherein Z is selected from the group consisting of hydrogen, and an unsubstituted aliphatic group containing 1 to 6 carbons; and
wherein n is a positive integer from 0 to 20.
5. The composition of claim 1 , wherein A is one of A1-A11:
6. The composition according to claim 4 , wherein Y is a methyl group and Z is hydrogen.
7. The composition according to claim 4 , wherein Y is hydrogen and Z is one of methyl or ethyl group.
8. The composition of claim 1 , wherein X is fluoride ion.
9. The composition of claim 1 , wherein R and R′ are the same.
10. The composition of claim 1 , wherein the composition is a dental composite.
11. The composition of claim 1 , wherein the composition is a denture based material.
12. The composition of claim 1 , wherein the composition is a dental bonding agent.
13. The composition of claim 1 , wherein the composition is a dental sealant.
14. The composition of claim 1 , wherein the composition is a dental resin cement.
15. The composition of claim 1 , wherein the composition is a resin-modified glass ionomer.
16. The composition of claim 1 , wherein the composition is a dental varnish.
17. The composition of claim 1 , wherein the composition is a mouth guard.
18. The composition of claim 1 , wherein the composition is a medical device.